Joseph W Laplume
EVP, Corp Strategy & Develop · 6 filings · Latest: Aug 10, 2026
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CRL | Joseph W Laplume | EVP, Corp Strategy & Develop | Mar 3, 2026 | Purchase | $174.54 | 25 | $4.4K | 27,448 | |
CRL | Joseph W Laplume | EVP, Corp Strategy & Develop | Aug 22, 2025 | Sale | $163.72 | 400 | $65.5K | 23,716 | |
CRL | Joseph LaPlume | — | Aug 22, 2025 | Proposed Sale | $152.50 | 400 | $61.0K | — | |
CRL | Joseph LaPlume | — | Aug 18, 2025 | Proposed Sale | $157.00 | 800 | $125.6K | — | |
CRL | Joseph LaPlume | — | Aug 7, 2025 | Proposed Sale | $150.00 | 400 | $60.0K | — | |
CRL | Joseph LaPlume | — | May 13, 2025 | Proposed Sale | $144.32 | 500 | $72.2K | — | |
CRL | Joseph LaPlume | — | Feb 20, 2025 | Proposed Sale | $165.00 | 4,400 | $726.0K | — |